Therapy-resistant tumor microvascular endothelial cells contribute to treatment failure in glioblastoma multiforme

Tijana Borovski(Amsterdam UMC Location University of Amsterdam), Martin R. Sprick(Heidelberg University), Jan Paul Medema(Amsterdam Neuroscience), Patrick Beke(Center for Translational Molecular Medicine), Joost Daalhuisen(Center for Translational Molecular Medicine), Valeria Lascano(Center for Translational Molecular Medicine), Hans M. Rodermond(Center for Translational Molecular Medicine), Joost J.C. Verhoeff(University Medical Center Utrecht), Olaf van Tellingen(Dutch Cancer Society)
Oncogene
May 21, 2012
10.1038/onc.2012.172
Cited by 58

Related Papers

The consensus molecular subtypes of colorectal cancer
|Nature Medicine|2015|5.3k
Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs
|Cell|1994|2.3k
FLICE is activated by association with the CD95 death‐inducing signaling complex (DISC)
|The EMBO Journal|1997|1.2k
Overcoming the blood–brain tumor barrier for effective glioblastoma treatment
|Drug Resistance Updates|2015|1k
Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins
|Proceedings of the National Academy of Sciences|1997|941